---
title: "Insulet Corporation — Publisher Overview"
type: publisher
publisher: "Insulet Corporation"
publisher_slug: "insulet-corporation"
canonical_url: "https://marlvel.ai/publishers/insulet-corporation"
last_updated: 2026-05-08T07:24:15.872Z
source: Marlvel.ai
license: CC-BY-NC-4.0
citation: "Marlvel.ai — Insulet Corporation Publisher Overview"
---
## ⚠ Content Warning

This publisher's portfolio includes apps classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This overview touches health-related apps. It is not medical advice.

---

# Insulet Corporation — Publisher Overview

> Supporting diabetes management through integrated insulin delivery control and educational simulation tools.

- **Publisher:** Insulet Corporation
- **Website:** [https://Omnipod.com](https://Omnipod.com)
- **Overview generated:** 2026-05-08
- **License:** CC-BY-NC 4.0

## Executive summary

Insulet operates as a specialized medical technology provider, anchoring its digital strategy on the integration of hardware-based insulin delivery systems with mobile software. Their primary moat is the regulatory and technical integration between their proprietary Pod hardware and continuous glucose monitoring (CGM) systems, creating a closed-loop ecosystem that is difficult for generic software competitors to replicate. The current strategic focus is on maintaining the stability of their core medical control application while providing educational simulators to lower the barrier to entry for new patients and caregivers.

## Publisher DNA

- **Primary focus:** Medical device integration and diabetes management software
- **Scale:** indie
- **Target audience:** Patients with diabetes, their caregivers, and healthcare providers requiring precise insulin therapy management.

## Portfolio momentum

- **Velocity:** active
- **Active apps:** 2
- **Abandoned apps:** 0
- **Last major release:** 34 days ago

Released 3 updates across the portfolio in the last 6 months, with the primary medical application receiving a major update within the last 34 days.

## Aggregated portfolio metrics

- **Total reviews (all apps):** 1,590
- **Weighted rating:** 3.38 / 5
- **Apps in portfolio:** 3

## Category breakdown

| Category | Apps | Share |
| :--- | :--- | :--- |
| Business | 1 | 33.3% |
| Health & Fitness | 1 | 33.3% |
| Medical | 1 | 33.3% |

## Top apps

- **Omnipod 5 App** — Flagship medical control tool with 1,466 reviews.
- **Omnipod® 5 Simulator** — Educational companion tool for system onboarding.
- **Insulet International Events** — Internal corporate logistics and networking utility.

## Signature patterns

- Strict focus on free-to-use utility and educational tools for medical hardware.
- Integration-heavy architecture connecting mobile apps to proprietary medical devices and sensors.
- Clear segmentation between patient-facing medical control, educational simulation, and internal corporate utility.

## Bottom line

Insulet leverages mobile software as a critical interface for their medical hardware, prioritizing functional reliability and regulatory compliance over consumer-grade engagement metrics. Their portfolio is a tightly controlled ecosystem designed to support the specific clinical needs of their device users.

---
© 2026 Marlvel.ai | [Publisher apps index](https://marlvel.ai/api/llm/publishers/insulet-corporation) | [Methodology](https://marlvel.ai/api/llm/methodology)
Data licensed under CC-BY-NC 4.0.

---
© 2026 Marlvel.ai | [Full publisher profile](https://marlvel.ai/publishers/insulet-corporation) | [Publisher apps index](https://marlvel.ai/api/llm/publishers/insulet-corporation) | [Methodology](https://marlvel.ai/api/llm/methodology)
Data licensed under CC-BY-NC 4.0.